NeuralMed - About the company
NeuralMed is a series A company based in Sao Paulo (Brazil), founded in 2018 by Anthony Eigier and Andre Castilla. It operates as a Provider of AI-based diagnosis platform for radiologists. NeuralMed has raised $4.35M in funding from investors like Inter-American Development Bank, Norte and Alexia Ventures. The company has 1071 active competitors, including 242 funded and 63 that have exited. Its top competitors include companies like Qure.ai, PathAI and HeartFlow.
Company Details
Provider of AI-based diagnosis platform for radiologists. The products provided are Manoel, harpy, and Emma. Manoel is a tool for chest X-ray screening. Emma is a solution that allows to classify and indicates the location of potential findings, contributing to the clinical decision-making process, and reducing the possibility of non-identification of findings.
- Website
- neuralmed.ai
- Social
- Email ID
- *****@neuralmed.ai
Key Metrics
Founded Year
2018
Location
Sao Paulo, Brazil
Stage
Series A
Total Funding
$4.35M in 4 rounds
Latest Funding Round
Investors
Ranked
156th among 1071 active competitors
Employee Count
14 as on Oct 31, 2026
Sign up to download NeuralMed's company profile
NeuralMed's funding and investors
NeuralMed has raised a total funding of $4.35M over 4 rounds. Its first funding round was on Mar 24, 2021. Its latest funding round was a Series A round on Nov 26, 2022 for $*****. 1 investor participated in its latest round. NeuralMed has 9 institutional investors.
Here is the list of recent funding rounds of NeuralMed:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 26, 2022 | 7307490 | Series A | 5182634 | 7206895 | 3592039 | 7799053 |
Nov 17, 2022 | 3964984 | Seed | 9174943 | 3588191 | 9056088 | 3579824 |
Aug 16, 2021 | 9244584 | Seed | 1386548 | 3728667 |
Access funding benchmarks and valuations. Sign up today!View details of NeuralMed's funding rounds and investors
NeuralMed's founders and board of directors
Founder? Claim ProfileThe founders of NeuralMed are Anthony Eigier and Andre Castilla.
Here are the details of NeuralMed's key team members:
- Anthony Eigier: Co-Founder of NeuralMed. Contact Info: 1 email address
- Andre Castilla: Co-Founder of NeuralMed. Contact Info: 1 email address
View details of NeuralMed's Founder profiles and Board Members
NeuralMed's employee count trend
NeuralMed has 14 employees as of Oct 26. Here is NeuralMed's employee count trend over the years:
Uncover NeuralMed's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NeuralMed's Competitors and alternates
Top competitors of NeuralMed include Qure.ai, PathAI and HeartFlow. Here is the list of Top 10 competitors of NeuralMed, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of artificial intelligence software for medical imaging diagnostic analysis | $139M | 74/100 | ||
2nd |  PathAI 2016, Boston (United States), Series C | Provider of digital pathology image management system for clinical labs | $255M | 71/100 | |
3rd |  HeartFlow 2007, Redwood City (United States), Public | Provides cardiovascular diagnostic support using analytics | $936M | 70/100 | |
4th |  AIdoc 2016, New York City (United States), Series E | Developer of clinical AI solutions for healthcare imaging and patient management | $534M | 69/100 | |
5th | Developer of medical imaging software for automated radiology diagnostic support | $6.69M | 68/100 | ||
6th |  Subtle Medical 2017, Palo Alto (United States), Series C | AI-driven solutions for medical diagnostic imaging | $86M | 66/100 | |
7th | Developer of artificial intelligence software for medical imaging diagnostic analysis | $40M | 65/100 | ||
8th |  Aignostics 2018, Berlin (Germany), Series B | Developer of artificial intelligence software for biomedical image analysis applications | $53.9M | 64/100 | |
9th | Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas | $23M | 64/100 | ||
10th | ScreenPoint 2014, Nijmegen (Netherlands), Series C | Developer of artificial intelligence software for analyzing breast imaging mammograms | $47M | 64/100 | |
156th | Provider of AI-based diagnosis platform for radiologists | $4.35M | 39/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on NeuralMed's competitors? Click here to see the top ones
NeuralMed's Investments and acquisitions
NeuralMed has made no investments or acquisitions yet.
Reports related to NeuralMed
Here is the latest report on NeuralMed's sector:
News related to NeuralMed
•
NeuralMed receives funding to reduce health system costsFusoes & Aquisicoes•Nov 18, 2022•NeuralMed, fmderraik.com.br, Kortex Ventures
•
With NeuralMed, Brazil’s NotreDame Group makes its first investment in start-upRio Times Online•Aug 16, 2021•NeuralMed
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about NeuralMed
Explore our recently published companies
- Hallway Talk - Denver based, 2014 founded, Unfunded company
- Shalom Hills - Gurugram based, 2004 founded, Unfunded company
- The Space Station - Unfunded company
- Ralph van Roosmalen - Unfunded company
- Universidad Virtual Hispanica de Mexico - Mexico based, Unfunded company
- BRANDOW'S FEED & SEED - Oneonta based, 2005 founded, Unfunded company
